The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours

European Journal of Surgical Oncology

Volumn 28, Issue 4, 2002, Pages 388-391

  Carmichael, A R ^a   Bendall, S ^a   Lockerbie, L ^b   Prescott, R ^b   Bates, T ^a  

^a WILLIAM HARVEY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DATA BASE; FAMILY HISTORY; FEMALE; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0036620227     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1266     Document Type: Article

References (32)

1. Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewart HJ. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70(9): 513-6.
2. Chaudary MA, Millis RR, Hoskins EO et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984; 71(9): 711-14.
3. Martin JK Jr, van Heerden JA, Gaffey TA. Synchronous and metachronous carcinoma of the breast. Surgery 1982; 91(1): 12-16.
4. Fracchia AA, Robinson D, Legaspi A, Greenall MJ, Kinne DW, Groshen S. Survival in bilateral breast cancer. Cancer 1985; 55(6): 1414-21.
5. Alexander AI, Mercer RJ, Muir IM, Mason B, Holdaway I. Predicting survival in bilateral breast carcinoma. Aust NZ J Surg 1989; 59(1): 35-7.
6. de la Rochefordiere RA, Asselain B, Scholl S et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994; 30(1): 35-41.
7. Mose S, Adamietz IA, Thilmann C et al. Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. Am J Clin Oncol 1997; 20(6): 541-5.
8. Newman LA, Sahin AA, Bondy ML et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 2001; 91(10): 1845-53.
9. Nomura Y, Tsutsui S, Murakami S, Takenaka Y. Prognostic impact of second cancer on the survival of early breast cancer patients. Int J Oncol 1999; 14(6): 1103-9.
10. Brenner H, Engelsmann B, Stegmaier C, Ziegler H. Clinical epidemiology of bilateral breast cancer. Cancer 1993; 72(12): 3629-35.
11. de la Rochefordiere RA, Mouret-Fourme E, Asselain B et al. Metachronous contralateral breast cancer as first event of relapse. Int J Radiat Oncol Biol Phys 1996; 36(3): 615-21.
12. Anastasiadis PG, Liberis VA, Koutlaki NG, Skaphida PG, Avgidou KE, Galazios GC. Incidence and detection of contralateral breast cancer. Breast J 2000; 6(3): 178-82.
13. Wanebo HJ, Senofsky GM, Fechner RE, Kaiser D, Lynn S, Paradies J. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg 1985; 201(6): 667-77.
14. Fisher ER, Fisher B, Sass R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). XI. Bilateral breast cancer. Cancer 1984; 54(12): 3002-11.
15. Sterns EE, Fletcher WA. Bilateral cancer of the breast: a review of clinical, histologic, and immunohistologic characteristics. Surgery 1991; 110(4): 617-22.
16. Broet P, de la Rochefordiere RA, Scholl SM et al. Contralateral breast cancer: annual Incidence and risk parameters. J Clin Oncol 1995: 13(7): 1578-83.
17. Hoffman E. The contralateral breast in ipsilateral breast carcinoma. South Med J 1990; 83(9): 1009-15.
18. Roubidoux MA, Helvie MA, Lai NE, Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology 1995; 196(2): 427-31.
19. Adami HO, Bergstrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 1985; 55(3): 643-7.
20. Rauschecker HF, Sauerbrei W, Gatzemeier W et al. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer 1998; 34(3): 315-23.
21. Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am J Epidemiol 1992; 136(8): 937-48.
22. Chaudary MA, Millis RR, Bulbrook RD, Hayward JL. Family history and bilateral primary breast cancer. Breast Cancer Res Treat 1985; 5(2): 201-5.
23. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997; 72(1): 54-65.
24. Bailey MJ, Royce C, Sloane JP, Ford HT, Powles TJ, Gazet JC. Bilateral carcinoma of the breast. Br J Surg 1980; 67(7): 514-6.
25. Berte E, Buzdar AU, Smith TL, Hortobagyi GN. Bilateral primary breast cancer in patients treated with adjuvant therapy. Am J Clin Oncol 1988; 11(2): 114-18.
26. Prior P, Waterhouse JA. The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours. Br J Cancer 1981; 43(5): 615-22.
27. Bloom ND, Daluvoy RV, Ceccarelli F, Degenshein GA. Bilateral mammary carcinoma; immunologic implications. NY State J Med 1980; 80(6): 908-10.
28. Burns PE, Dabbs K, May C et al. Bilateral breast cancer in Northern Alberta: risk factors and survival patterns. Can Med Assoc J 1984: 130(7): 881-6.
29. Gustafsson A, Tartter PI, Brower ST, Lesnick G. Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg 1994; 178(2): 111-16.
30. Kollias J, Ellis IO, Elston CW, Blamey RW. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 2001; 25(9): 1117-24.
31. Heaton KM, Peoples GE, Singletary SE et al. Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol 1999; 6(1): 102-8.
32. Murphy TJ, Conant EF, Hanau CA, Ehrlich SM, Feig SA. Bilateral breast carcinoma: mammographic and histologic correlation. Radiology 1995; 195(3): 617-21.